SERVICING AGREEMENT dated as of February 28, 2020 between TRIPLE ROYALTY SUB II LLC and THERAVANCE BIOPHARMA US, INC.Servicing Agreement • March 4th, 2020 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2020 Company Industry JurisdictionThis SERVICING AGREEMENT, dated as of February 28, 2020 (this “Servicing Agreement”), is entered into between Triple Royalty Sub II LLC, a Delaware limited liability company, as the issuer (the “Issuer”), and Theravance Biopharma US, Inc. (“Theravance Biopharma US”), a Delaware corporation, as the servicer (together with its permitted successors and assigns in such capacity, the “Servicer”).
SERVICING AGREEMENT dated as of November 30, 2018 between TRIPLE ROYALTY SUB LLC and THERAVANCE BIOPHARMA R&D, INC.Servicing Agreement • December 3rd, 2018 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 3rd, 2018 Company Industry JurisdictionThis SERVICING AGREEMENT, dated as of November 30, 2018 (this “Servicing Agreement”), is entered into between Triple Royalty Sub LLC, a Delaware limited liability company, as the issuer (the “Issuer”), and Theravance Biopharma R&D, Inc. (“Theravance Biopharma R&D”), a Cayman Islands exempted company, as the servicer (together with its permitted successors and assigns in such capacity, the “Servicer”).